Paris, France

Odile Le Martret

This inventor holds 50 USPTO granted patents, primarily in Analgesic Compounds (CPC class 5461). Top assignees: Roussel Uclaf, Hoechst Marion Roussel, Other. Active years: 1976-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 14

Forward Citations = 625(Granted Patents)

Forward Citations (Not Self Cited) = 598(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • de Versailles, FR (1998)
  • Paris, FR (1976 - 2001)

Company Filing History:


Years Active: 1976-2001

Loading Chart...
Areas of Expertise:
Erythromycin
Decahydroquinolines
Indanes
Pyridones
Analgesics
Anti-inflammatory
Quinoline
Hydroquinolines
Pain Treatment
N-substituted Derivatives
Amino Compounds
Carboxylic Acid
50 patents (USPTO):Explore Patents

Title: The Innovative Journey of Odile Le Martret

Introduction: Odile Le Martret is a pioneering inventor hailing from the vibrant city of Paris, France. Her groundbreaking work in the field of inventions has left a lasting impact on the industry.

Latest Patents: Odile Le Martret holds several patents in various technological fields, showcasing her versatility and creativity as an inventor. Her recent patents focus on sustainable energy solutions and advanced medical devices.

Career Highlights: With a career spanning over two decades, Odile Le Martret has consistently pushed the boundaries of innovation. Her contributions to the development of eco-friendly technologies have earned her recognition on a global scale.

Collaborations: Throughout her career, Odile Le Martret has collaborated with leading research institutions and universities to further her inventions. Her ability to work in multidisciplinary teams has led to the successful implementation of cutting-edge ideas.

Conclusion: Odile Le Martret's dedication to innovation and her passion for creating a better future through inventions make her a true trailblazer in the world of technology. Her work continues to inspire aspiring inventors worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…